- Canada’s phased legalization of recreational-use cannabis highlights unfolding opportunities in the cannabis space
- ChineseInvestors.com is continuing to build its presence in the cannabis space while pressing its advantage among Chinese-speaking consumers
- The company is pursuing the possibility of a Nasdaq IPO for its cannabis industry subsidiary later this year, and it’s also contemplating a move to the NYSE or Nasdaq Small Cap Market
- Company recently appointed Patrick Leung as its new CFO
Chinese language investor education service provider ChineseInvestors.com Inc. (OTCQB: CIIX) is flying high as it explores Canada’s unfolding opportunities for the cannabis retail space and the possibility of a Nasdaq IPO for wholly owned cannabis industry subsidiary CBD Biotechnology Co. Ltd. later in the current fiscal year (http://ibn.fm/EqVoL), bolstering its ambition for an uplisting to the New York Stock Exchange or Nasdaq Small Cap Market within the next few years as the company reaches up to $10 million in annual volume. In addition, the company recently appointed Patrick Leung as its new CFO.
“I smell this tremendous, tremendous opportunity for (a) Chinese cannabis company like us… I think of the tremendous opportunities here because there’s not many competitors in the world like us, doing the cannabis business for Chinese people,” ChineseInvestors.com CEO Warren Wang said in a December interview (http://ibn.fm/r1S27).
Wang said that cannabis is one of the twin engines driving CIIX’s flight plan, the other being bitcoin, although bitcoin has been relegated to a backup position at the company’s investors’ request until its market position revives, he indicated. Following up on the Chinese New Year in February, ChineseInvestors.com is hoping to capitalize on cultural expectations for wealth and well-being during the coming year. CBD Biotechnology recently launched its first self-branded rice wine labeled ‘Hemp Wine’ (http://ibn.fm/pZMuE), and CIIX’s second quarter report noted a revenue increase of more than 50 percent year-over-year (http://ibn.fm/9zrSn).
While cannabis use in China is illegal, hemp-based CBD can be legally added to cosmetics, thus opening a potential market of nearly two billion people for the company. In the United States, the company is based in San Gabriel, California, amid the nation’s largest cannabis market.
ChineseInvestors.com is celebrating the advancing tide of cannabis legalization in the United States, including the Georgia House of Representatives vote this month and the governor’s accompanying plan to regulate the manufacture and sale of medical marijuana oil.
The company’s core focus is on offering investment education to its Chinese-speaking audience through real-time market commentary, video reports, podcasts and an online site, utilizing Chinese language character sets (both traditional and simplified). CIIX also provides consulting services to smaller private firms considering their public-listing options, as well as advertising and public business-related support services.
The company is working with Medicine Man Denver to establish a new intellectual property and experience-based corporate entity that will provide licensing and consulting services within the cannabis sector.
For more information, visit the company’s website at www.ChineseInvestors.com
NOTE TO INVESTORS: The latest news and updates relating to CIIX are available in the company’s newsroom at http://ibn.fm/CIIX
